Doxylamine Succinate; Pyridoxine Hydrochloride Patent Expiration
Doxylamine Succinate; Pyridoxine Hydrochloride is Used for treating nausea and vomiting of pregnancy in women who do not respond to conservative management. It was first introduced by Sanofi Aventis Us Llc
Doxylamine Succinate; Pyridoxine Hydrochloride Patents
Given below is the list of patents protecting Doxylamine Succinate; Pyridoxine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bonjesta | US7560122 | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
Jan 25, 2019
(Expired) | Duchesnay |
| Bonjesta | US9089489 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Bonjesta | US9375404 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Bonjesta | US9526703 | Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Bonjesta | US9937132 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Diclegis | US6340695 | Rapid onset formulation |
Jun 21, 2021
(Expired) | Duchesnay |
| Diclegis | US7560122 | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
Jan 25, 2019
(Expired) | Duchesnay |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Doxylamine Succinate; Pyridoxine Hydrochloride Generics
Several generic applications have been filed for Doxylamine Succinate; Pyridoxine Hydrochloride. The first generic version for Doxylamine Succinate; Pyridoxine Hydrochloride was by Actavis Laboratories Fl Inc and was approved on Aug 19, 2016. And the latest generic version is by Bionpharma Inc and was approved on Aug 4, 2023.
Given below is the list of companies who have filed for Doxylamine Succinate; Pyridoxine Hydrochloride generic.
1. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 1 generic for Doxylamine Succinate; Pyridoxine Hydrochloride. This 10mg;10mg version comes by the name DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG; 10MG | tablet, delayed release | Prescription | ORAL | AB | Jul 6, 2020 |
2. BIONPHARMA
Bionpharma Inc has filed for 1 generic for Doxylamine Succinate; Pyridoxine Hydrochloride. This 10mg;10mg version comes by the name DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG; 10MG | tablet, delayed release | Prescription | ORAL | AB | Aug 4, 2023 |
3. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Doxylamine Succinate; Pyridoxine Hydrochloride. This 10mg;10mg version comes by the name DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG; 10MG | tablet, delayed release | Prescription | ORAL | AB | Dec 6, 2017 |
4. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Doxylamine Succinate; Pyridoxine Hydrochloride. All of these versions come by the name DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG; 10MG | tablet, delayed release | Prescription | ORAL | AB | Aug 19, 2016 |
| 20MG; 20MG | tablet, extended release | Discontinued | ORAL | N/A | Mar 1, 2022 |